Organization

GuardantHealth

2 abstracts

Abstract
Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial.
Org: BC Cancer-Vancouver Centre, Pancreas Centre BC, Canadian Cancer Trials Group, Queen's University, Belfast, Providence Cancer Institute,